Piggybac transposon somatic mutagenesis with an activated reporter and tracker (PB-SMART) for genetic screens in mice

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Landrette, Sean F ^a   Cornett, Jonathan C ^a   Ni, Thomas K ^a   Bosenberg, Marcus W ^b   Xu, Tian ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; LUCIFERASE; RED FLUORESCENT PROTEIN; TRANSPOSASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CELL INFILTRATION; CELL MUTANT; CELL TRACKING; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FEMALE; FLUORESCENCE ANALYSIS; GENE IDENTIFICATION; GENE INSERTION; GENE MAPPING; GENETIC CROSS; GENETIC SCREENING; GERMLINE MICRONUCLEUS; MALE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PROCESS DEVELOPMENT; REPORTER GENE; SITE DIRECTED MUTAGENESIS; SOMATIC MUTAGENESIS WITH AN ACTIVATED REPORTER AND TRACKER; SOMATIC MUTATION; TRANSPOSON; TUMOR CELL LINE; TUMOR GROWTH; ANIMAL; MUTAGENESIS;

ANIMALIA; HARNESS; MAMMALIA; MUS;

ANIMALS; DNA TRANSPOSABLE ELEMENTS; GENES, REPORTER; MICE; MUTAGENESIS;

EID: 80054844707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026650     Document Type: Article

References (47)

1. Cooley L, Kelley R, Spradling A, (1988) Insertional mutagenesis of the Drosophila genome with single P elements. Science 239: 1121-1128.
2. Kleckner N, Roth J, Botstein D, (1977) Genetic engineering in vivo using translocatable drug-resistance elements. New methods in bacterial genetics. J Mol Biol 116: 125-159.
3. Ding S, Wu X, Li G, Han M, Zhuang Y, et al. (2005) Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 122: 473-483.
4. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z, (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510.
5. Wu S, Ying G, Wu Q, Capecchi MR, (2007) Toward simpler and faster genome-wide mutagenesis in mice. Nat Genet 39: 922-930.
6. Bender AM, Collier LS, Rodriguez FJ, Tieu C, Larson JD, et al. Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas. Cancer Res pp. 3557-3565.
7. Collier LS, Adams DJ, Hackett CS, Bendzick LE, Akagi K, et al. (2009) Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res 69: 8429-8437.
8. Collier LS, Carlson CM, Ravimohan S, Dupuy AJ, Largaespada DA, (2005) Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436: 272-276.
9. Dupuy AJ, Akagi K, Largaespada DA, Copeland NG, Jenkins NA, (2005) Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436: 221-226.
10. Dupuy AJ, Rogers LM, Kim J, Nannapaneni K, Starr TK, et al. (2009) A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 69: 8150-8156.
11. Keng VW, Villanueva A, Chiang DY, Dupuy AJ, Ryan BJ, et al. (2009) A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 27: 264-274.
12. Rad R, Rad L, Wang W, Cadinanos J, Vassiliou G, et al. (2011) PiggyBac Transposon Mutagenesis: A Tool for Cancer Gene Discovery in Mice. Science 330 (6007): 1104-7.
13. Starr TK, Allaei R, Silverstein KA, Staggs RA, Sarver AL, et al. (2009) A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323: 1747-1750.
14. Lee T, Luo L, (2001) Mosaic analysis with a repressible cell marker (MARCM) for Drosophila neural development. Trends Neurosci 24: 251-254.
15. Pagliarini RA, Xu T, (2003) A genetic screen in Drosophila for metastatic behavior. Science 302: 1227-1231.
16. White RM, Sessa A, Burke C, Bowman T, LeBlanc J, et al. (2008) Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2: 183-189.
17. Xu T, Rubin GM, (1993) Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 117: 1223-1237.
18. Elick TA, Bauser CA, Fraser MJ, (1996) Excision of the piggyBac transposable element in vitro is a precise event that is enhanced by the expression of its encoded transposase. Genetica 98: 33-41.
19. de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S, (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7: 725-737.
20. Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, et al. (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41: 544-552.
21. Dankort D, Filenova E, Collado M, Serrano M, Jones K, et al. (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 21: 379-384.
22. Davis IJ, Hsi BL, Arroyo JD, Vargas SO, Yeh YA, et al. (2003) Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci U S A 100: 6051-6056.
23. Kuiper RP, Schepens M, Thijssen J, van Asseldonk M, van den Berg E, et al. (2003) Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet 12: 1661-1669.
24. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, et al. (1996) The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 5: 1333-1338.
25. Weterman MA, Wilbrink M, Geurts van Kessel A, (1996) Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci U S A 93: 15294-15298.
26. Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, et al. (2001) Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159: 179-192.
27. Haq R, Fisher DE, Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer. J Clin Oncol 29: 3474-3482.
28. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, et al. (2000) Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet 24: 216-217.
29. Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H, (1999) Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development 126: 3915-3924.
30. Roessler E, Ermilov AN, Grange DK, Wang A, Grachtchouk M, et al. (2005) A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2. Hum Mol Genet 14: 2181-2188.
31. Gorlin RJ, (1987) Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 66: 98-113.
32. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, et al. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272: 1668-1671.
33. Beauchamp E, Bulut G, Abaan O, Chen K, Merchant A, et al. (2009) GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. J Biol Chem 284: 9074-9082.
34. Joo J, Christensen L, Warner K, States L, Kang HG, et al. (2009) GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors. PLoS One 4: e7608.
35. Yuan Y, Altman S, (1995) Substrate recognition by human RNase P: identification of small, model substrates for the enzyme. EMBO J 14: 159-168.
36. Dassule HR, Lewis P, Bei M, Maas R, McMahon AP, (2000) Sonic hedgehog regulates growth and morphogenesis of the tooth. Development 127: 4775-4785.
37. Shao X, Somlo S, Igarashi P, (2002) Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 13: 1837-1846.
38. Bosenberg M, Muthusamy V, Curley DP, Wang Z, Hobbs C, et al. (2006) Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis 44: 262-267.
39. Lechler T, Fuchs E, (2005) Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 437: 275-280.
40. Arnold I, Watt FM, (2001) c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol 11: 558-568.
41. Waikel RL, Kawachi Y, Waikel PA, Wang XJ, Roop DR, (2001) Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet 28: 165-168.
42. Epstein EH, (2008) Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 8: 743-754.
43. Wang GY, Wang J, Mancianti EH Jr, Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+/-) mice. Cancer Cell 19: 114-124.
44. Youssef KK, Van Keymeulen A, Lapouge G, Beck B, Michaux C, et al. Identification of the cell lineage at the origin of basal cell carcinoma. Nat Cell Biol 12: 299-305.
45. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI, (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 23: 1686-1690.
46. Wu X, Wu J, Huang J, Powell WC, Zhang J, et al. (2001) Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 101: 61-69.
47. Uren AG, Mikkers H, Kool J, van der Weyden L, Lund AH, et al. (2009) A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites. Nat Protoc 4: 789-798.